Adherence to Antimalarial Drugs in Sierra Leone

NACompletedINTERVENTIONAL
Enrollment

1,145

Participants

Timeline

Start Date

September 16, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
Malaria
Interventions
DRUG

amodiaquine-artesunate (AQAS) fixed-dose

DRUG

Artemether-lumefantrine combination (AL) dispersable

Trial Locations (2)

Unknown

George Brook Health Center, Freetown

Ross Road Health Facility, Freetown

All Listed Sponsors
collaborator

National Malaria Control Program, Ministry of Health and Sanitation

UNKNOWN

collaborator

Pharmacy Board of Sierra Leone, Ministry of Health and Sanitation

UNKNOWN

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT01967472 - Adherence to Antimalarial Drugs in Sierra Leone | Biotech Hunter | Biotech Hunter